2012 Summer Project Week:TimeSeriesMonitoringIntracranialBones

From NAMIC Wiki
Revision as of 15:10, 15 June 2012 by Ktdiedrich (talk | contribs) (Time series monitoring of intracranial bones for watchful waiting of meningioma.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Home < 2012 Summer Project Week:TimeSeriesMonitoringIntracranialBones


Key Investigators

  • AZE Research and Development, Cambridge, MA: Karl Diedrich

Objective

  • The goal of this project is to increase the performance (sensitivity and specificity) of detection of bone involvement in meningioma. Meningiomas are the most common form of intracranial tumor [1]. Meningiomas are either managed by watchful waiting or treated by resection and optional radiation therapy [2]. Bone involvement signals a more dangerous form of disease with increased death rates and recurrence after treatment warranting more aggressiveness treatment [2], [3]. Bone involvement is detected by radiographic evidence of hyperostosis, bone sclerosis or osteolytic lesions [2]. Watchful waiting involves repeated time series imaging of patients by magnetic resonance imaging (MRI) following initial discovery often by computed tomography (CT).
  • Learn to develop Slicer commandline extensions
  • Learn to develop Slicer modules

Approach, Plan

  • Segment the intracranial bones by thresholding the intensity by histogram and keeping the largest connected component
  • Rigid register the time series bone tissue. The sparse data from the segmentation will be converted into a filled out distance map for gradient descent optimization using the mutual information cost function for intermodality CT MRI registration.

Progress

  • Segmented part of intracranial bone by intensity threshold.
  • Turned the bone into a distance map and registered bone on the distance map.

Delivery Mechanism

Distance map module.

  • Slicer Module
  • Extension -- commandline

References

  1. J. Wiemels, M. Wrensch, and E. B. Claus, “Epidemiology and etiology of meningioma,” J. Neurooncol., vol. 99, no. 3, pp. 307–314, Sep. 2010.
  2. D. Gabeau-Lacet, M. Aghi, R. A. Betensky, F. G. Barker, J. S. Loeffler, and D. N. Louis, “Bone Involvement Predicts Poor Outcome in Atypical Meningioma,” J Neurosurg, vol. 111, no. 3, pp. 464–471, Sep. 2009.
  3. R. Graf, M. Plotkin, I. G. Steffen, R. Wurm, P. Wust, W. Brenner, V. Budach, and H. Badakhshi, “Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series,” Head Face Med, vol. 8, p. 1, 2012.